"Even drugs that actually make it to clinical trial - that seem to be working really well in animal models - fail dramatically in clinic," he said in a press conference. "That tells us we're missing a lot of information about human biology and capturing that will be essential."
Part-human part-mouse brain developed in science breakthrough
Why This Matters
Scientists have created a chimeric brain model combining human and mouse neural tissue, aiming to close the long-standing gap between animal testing and human biology. This matters because so many drugs that succeed in animal trials fail in humans, wasting enormous time and resources in medical research; a more human-relevant model could improve the success rate of new treatments.
Key Takeaways
- Many promising drugs fail in human clinical trials despite success in animal models, revealing gaps in traditional research methods.
- A new part-human, part-mouse brain model aims to better capture human-specific biology for research.
- This breakthrough could improve the reliability of preclinical testing and potentially speed up development of effective treatments.
Explore topics:
human-mouse chimeric brain
clinical trials
animal models
human biology
brain research
Get alerts for these topics